435 related articles for article (PubMed ID: 29177594)
1. Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
Cardona AF; Rojas L; Wills B; Bernal L; Ruiz-Patiño A; Arrieta O; Hakim EJ; Hakim F; Mejía JA; Useche N; Bermúdez S; Carranza H; Vargas C; Otero J; Mayor LC; Ortíz LD; Franco S; Ortíz C; Gil-Gil M; Balaña C; Zatarain-Barrón ZL
J Neurooncol; 2018 Jan; 136(2):363-371. PubMed ID: 29177594
[TBL] [Abstract][Full Text] [Related]
2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-epileptic drugs on the survival of patients with glioblastoma multiforme: A retrospective, single-center study.
Ryu JY; Min KL; Chang MJ
PLoS One; 2019; 14(12):e0225599. PubMed ID: 31790459
[TBL] [Abstract][Full Text] [Related]
4. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.
Kerkhof M; Dielemans JC; van Breemen MS; Zwinkels H; Walchenbach R; Taphoorn MJ; Vecht CJ
Neuro Oncol; 2013 Jul; 15(7):961-7. PubMed ID: 23680820
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
Kanemura H; Sano F; Ohyama T; Aihara M
Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
Zeng TF; Li YH; An DM; Chen L; Lei D; Zhang B; Li JM; Zhou D
Epilepsy Res; 2014 Dec; 108(10):1904-11. PubMed ID: 25454502
[TBL] [Abstract][Full Text] [Related]
8. Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
Santhosh AP; Kumar Goyal M; Modi M; Kharbanda PS; Ahuja CK; Tandyala N; Prabhat N; Singh R; Mehta S; Vinay Mahesh K
Acta Neurol Scand; 2021 Mar; 143(3):242-247. PubMed ID: 33006755
[TBL] [Abstract][Full Text] [Related]
9. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
[TBL] [Abstract][Full Text] [Related]
11. Does the choice of antiepileptic drug affect survival in glioblastoma patients?
Knudsen-Baas KM; Engeland A; Gilhus NE; Storstein AM; Owe JF
J Neurooncol; 2016 Sep; 129(3):461-469. PubMed ID: 27377653
[TBL] [Abstract][Full Text] [Related]
12. Quality of life after switching to generic levetiracetam - A prospective comparative study.
Olsson P; Reimers A; Källén K
Epilepsy Behav; 2019 Jul; 96():169-174. PubMed ID: 31150996
[TBL] [Abstract][Full Text] [Related]
13. Comparing the efficacy of sodium valproate and levetiracetam following initial lorazepam in elderly patients with generalized convulsive status epilepticus (GCSE): A prospective randomized controlled pilot study.
Nene D; Mundlamuri RC; Satishchandra P; Prathyusha PV; Nagappa M; Bindu PS; Raghavendra K; Saini J; Bharath RD; Thennarasu K; Taly AB; Sinha S
Seizure; 2019 Feb; 65():111-117. PubMed ID: 30682680
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam therapy in patients with brain tumour and epilepsy.
Maschio M; Albani F; Baruzzi A; Zarabla A; Dinapoli L; Pace A; Pompili A; Carapella CM; Occhipinti E; Jandolo B
J Neurooncol; 2006 Oct; 80(1):97-100. PubMed ID: 16685465
[TBL] [Abstract][Full Text] [Related]
15. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
Chonan M; Saito R; Kanamori M; Osawa SI; Watanabe M; Suzuki H; Nakasato N; Tominaga T
Neurol Med Chir (Tokyo); 2020 Jan; 60(1):37-44. PubMed ID: 31748440
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
17. The risk of hypotension and seizures in patients receiving prophylactic anti-epileptic drugs for supratentorial craniotomy.
Höhne J; Schebesch KM; Ott C; Brawanski A; Lange M
J Neurosurg Sci; 2018 Aug; 62(4):418-422. PubMed ID: 27854111
[TBL] [Abstract][Full Text] [Related]
18. Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
Happold C; Gorlia T; Chinot O; Gilbert MR; Nabors LB; Wick W; Pugh SL; Hegi M; Cloughesy T; Roth P; Reardon DA; Perry JR; Mehta MP; Stupp R; Weller M
J Clin Oncol; 2016 Mar; 34(7):731-9. PubMed ID: 26786929
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
[TBL] [Abstract][Full Text] [Related]
20. A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy.
Rao LM; Hussain SA; Zaki T; Cho A; Chanlaw T; Garg M; Sankar R
Epilepsy Behav; 2018 Nov; 88():212-217. PubMed ID: 30296665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]